Pittsburgh, January 22, 2013 — Bayer MaterialScience LLC today announced it has completed the purchase of nearly 11 acres of land located directly adjacent to its South Deerfield Site. This investment in additional land demonstrates Bayer's commitment to the Functional Films NAFTA business and allows for future expansion of the site. This follows other investments over the past several years that further expanded and improved specialty film production capabilities at the site.
"Bayer MaterialScience is committed to its specialty films business in North America, and this land purchase supports our future growth plans for this important region," said Dr. Shaun Gaus, general manager, Functional Films NAFTA, Bayer MaterialScience LLC. The South Deerfield facility manufactures and sells thermoplastic polyurethane (TPU), polycarbonate (PC) and polycarbonate blend, and other specialty film and sheet for use in various market segments, including medical, automotive, sports/recreation, and safety & security. The 147,000-square-foot facility is ISO 9001 registered.
About Bayer MaterialScience LLC:
Bayer MaterialScience LLC is one of the leading producers of polymers and high-performance plastics in North America and is part of the global Bayer MaterialScience business with approximately 14,800 employees at 30 production sites around the world and 2011 sales of 10.8 billion euros. Bayer MaterialScience's 2011 sales in North America were $2.9 billion. The company manufactures high-tech polymer materials and develops innovative solutions for products used in many areas of daily life. The main segments served are the automotive, electrical and electronics, construction, medical, and sports and leisure industries. Sustainability is central to Bayer MaterialScience LLC's business and is based around the key areas of innovation, product stewardship, excellence in corporate management, social responsibility and respect for the environment.
# # #
This website may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.
Name: Katie Kirkpatrick